Drug search by name

Talazoparib Tosylate and Hepatic impairment

Result of checking the interaction of drug Talazoparib Tosylate and disease Hepatic impairment for safety when used together.

Check result:

Talazoparib Tosylate <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Talazoparib has not been studied in patients with moderate hepatic impairment (total bilirubin >1.5 to 3.0 × upper limit of normal [ULN] and any aspartate aminotransferase [AST]) or severe hepatic impairment (total bilirubin >3.0 × ULN and any AST). No dose adjustment is required for patients with mild hepatic impairment (total bilirubin =1 × ULN and AST > ULN, or total bilirubin >1.0 to 1.5 × ULN and any AST).

Talazoparib Tosylate

Generic Name: talazoparib

Brand Name: Talzenna

Synonyms: Talazoparib

What is Talazoparib Tosylate?